PTGS2 and neoplasm: For example, in mouse H22 hepatocarcinoma model, inhibition of COX-2 by celecoxib reduced tumor growth and MVD through inhibition of PTEN/PI3K/Akt/HIF-1 signaling pathway in tumor cells [269].